These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33791385)

  • 1. Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
    Li D; Sun F
    Biomed Res Int; 2021; 2021():9514279. PubMed ID: 33791385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.
    Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS
    Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin Type A Injection for Correction of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
    Yang J; Hu X; Li Q; Huang RL
    J Craniofac Surg; 2023 Jul-Aug 01; 34(5):e485-e488. PubMed ID: 37221639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Triamcinolone acetonide deep fornix injection for the treatment of upper eyelid retraction in patients with thyroid-associated ophthalmopathy].
    Luo LH; Gao LX; Wang W; Miao H; Ma XM; Li DM
    Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):524-529. PubMed ID: 32842335
    [No Abstract]   [Full Text] [Related]  

  • 5. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy.
    Xu D; Liu Y; Xu H; Li H
    Can J Ophthalmol; 2012 Feb; 47(1):34-41. PubMed ID: 22333849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An algorithm for Botulinum toxin A injection for upper eyelid retraction associated with thyroid eye disease: long-term results.
    Ozturk Karabulut G; Fazil K; Saracoglu Yilmaz B; Ozturker C; Günaydın ZK; Taskapili M; Kaynak P
    Orbit; 2021 Oct; 40(5):381-388. PubMed ID: 32885692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease.
    Lee JM; Lee H; Park M; Baek S
    J Craniofac Surg; 2012 Nov; 23(6):1755-8. PubMed ID: 23147303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease.
    Salour H; Bagheri B; Aletaha M; Babsharif B; Kleshadi M; Abrishami M; Bagheri A
    Orbit; 2010 Apr; 29(2):114-8. PubMed ID: 20394553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
    Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
    J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphometric analysis of the palpebral fissure in patients with thyroid-related disfunction before and after application of botulinum toxin].
    Costa PG; Saraiva FP; Matayoshi S
    Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):920-5. PubMed ID: 17160217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series.
    Chee E; Chee SP
    Eye (Lond); 2008 Feb; 22(2):311-5. PubMed ID: 17917686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage.
    Costa PG; Saraiva FP; Pereira IC; Monteiro ML; Matayoshi S
    Eye (Lond); 2009 Apr; 23(4):767-73. PubMed ID: 18535592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction].
    Wabbels B; Förl M
    Ophthalmologe; 2007 Sep; 104(9):771-6. PubMed ID: 17823804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in upper eyelid position after teprotumumab treatment for thyroid eye disease.
    Rosenblatt TR; Chiou CA; Yoon MK; Lee NG; Wolkow N; Freitag SK
    Orbit; 2024 Jun; 43(3):337-343. PubMed ID: 38466206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction--a pilot study.
    Träisk F; Tallstedt L
    Acta Ophthalmol Scand; 2001 Dec; 79(6):585-8. PubMed ID: 11782224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease-A New Injection Method.
    Young SM; Kim YD; Lang SS; Woo KI
    Ophthalmic Plast Reconstr Surg; 2018; 34(6):587-593. PubMed ID: 29672347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type a for dysthyroid upper eyelid retraction.
    Morgenstern KE; Evanchan J; Foster JA; Cahill KV; Burns JA; Holck DE; Perry JD; Wulc AE
    Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):181-5. PubMed ID: 15167723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acellular xenogenic dermal matrix as a spacer graft for treatment of eyelid retraction related to thyroid associated ophthalmopathy].
    Zhuang A; Sun J; Zhang S; Zhou HF
    Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):821-827. PubMed ID: 31715678
    [No Abstract]   [Full Text] [Related]  

  • 19. Peri-levator palpebrae superioris triamcinolone injection for the treatment of thyroid eye disease-associated upper eyelid retraction.
    Joos ZP; Sullivan TJ
    Clin Exp Ophthalmol; 2017 Aug; 45(6):651-652. PubMed ID: 28248444
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonsurgical treatment for upper eyelid retraction in patients with inactive Graves' orbitopathy.
    Vokurka Topljak S; Galiot Delić M; Mandić K; Perić S; Baretić M; Juri Mandić J
    Int Ophthalmol; 2023 Jul; 43(7):2291-2299. PubMed ID: 36587368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.